Wang Xin - Meihua International CEO Director
| MHUA Stock | USD 0.53 0.01 1.85% |
Insider
Wang Xin is CEO Director of Meihua International Medical
| Age | 35 |
| Address | 88 Tongda Road, Yangzhou, China, 225000 |
| Phone | 86 051 4898 00199 |
| Web | https://www.meihuamed.com |
Meihua International Management Efficiency
The company has return on total asset (ROA) of 0.042 % which means that it generated a profit of $0.042 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0642 %, meaning that it created $0.0642 on every $100 dollars invested by stockholders. Meihua International's management efficiency ratios could be used to measure how well Meihua International manages its routine affairs as well as how well it operates its assets and liabilities. As of December 1, 2024, Return On Tangible Assets is expected to decline to 0.07. In addition to that, Return On Capital Employed is expected to decline to 0.09. At present, Meihua International's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 15.59, whereas Net Tangible Assets are forecasted to decline to about 80.9 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rebecca Kuhn | Neuropace | 63 | |
| Christopher Yamamoto | Bioventus | N/A | |
| Karen Prange | Nevro Corp | 56 | |
| Andre Marquette | Neuropace | N/A | |
| Julie Dewey | Nevro Corp | 63 | |
| Anthony James | Bioventus | N/A | |
| Joseph Powers | Si Bone | 64 | |
| Rashed Dewan | Profound Medical Corp | 56 | |
| Kenneth Reali | Bioventus | 58 | |
| Michael Carter | Nevro Corp | 52 | |
| Arun MBA | Profound Medical Corp | 69 | |
| Levant Tinaz | Profound Medical Corp | N/A | |
| Ehab Esmail | Orthofix Medical | 52 | |
| Donald Middlebrook | Nevro Corp | 69 | |
| Miguel BeltranDelgado | Bioventus | N/A | |
| Katrina Church | Bioventus | 62 | |
| Richard Carter | Nevro Corp | 53 | |
| BA Chemistry | Orthofix Medical | 63 | |
| Mark Saxton | Neuropace | 59 | |
| Mark Quick | Orthofix Medical | N/A | |
| Stephen Kilmer | Profound Medical Corp | N/A | |
Management Performance
| Return On Equity | 0.0642 | ||||
| Return On Asset | 0.042 |
Meihua International Management Team
Elected by the shareholders, the Meihua International's board of directors comprises two types of representatives: Meihua International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Meihua. The board's role is to monitor Meihua International's management team and ensure that shareholders' interests are well served. Meihua International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Meihua International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yulin Wang, CEO CFO | ||
| Wang Xin, CEO Director | ||
| Lianzhang Zhao, Chief Officer |
Meihua Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Meihua International a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0642 | ||||
| Return On Asset | 0.042 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 7.06 M | ||||
| Shares Outstanding | 26.09 M | ||||
| Shares Owned By Insiders | 56.47 % | ||||
| Shares Owned By Institutions | 8.70 % | ||||
| Number Of Shares Shorted | 401.93 K | ||||
| Price To Earning | 13.75 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Meihua International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Meihua International's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Meihua International Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Meihua International Medical Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Meihua International Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Meihua International. If investors know Meihua will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Meihua International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.42) | Earnings Share 0.37 | Revenue Per Share 3.847 | Quarterly Revenue Growth (0.06) | Return On Assets 0.042 |
The market value of Meihua International is measured differently than its book value, which is the value of Meihua that is recorded on the company's balance sheet. Investors also form their own opinion of Meihua International's value that differs from its market value or its book value, called intrinsic value, which is Meihua International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Meihua International's market value can be influenced by many factors that don't directly affect Meihua International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Meihua International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Meihua International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Meihua International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.